GNRH1 and eosinophilia-myalgia syndrome: Considering EMs as an estrogen-dependent disease, the most common and effective pharmacological treatment is to inhibit the growth of intrinsic estrogen by altering gonadotropin-releasing hormone (GRH) (Giudice, 2010).